0.4838
price down icon1.51%   -0.0074
after-market Handel nachbörslich: .49 0.0062 +1.28%
loading

Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten

pulisher
01:11 AM

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

01:11 AM
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com

Apr 25, 2025
pulisher
Apr 24, 2025

Tenaya reports progress in ARVC gene therapy study - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan

Apr 24, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia

Apr 18, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - The Manila Times

Apr 04, 2025
pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 01, 2025

Tenaya highlights HCM gene therapy interim data at ACC 2025 - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Tenaya to lay off about one-third of staff, reveals heart gene therapy data - Endpoints News

Mar 31, 2025
pulisher
Mar 31, 2025

Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Tenaya Therapeutics Announces Late Breaker Presentation - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Revolutionary Gene Therapy Transforms Severe Heart Disease Patients in Landmark Trial - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting - The Manila Times

Mar 31, 2025
pulisher
Mar 28, 2025

Undervalued Cardiology Stocks to Watch: TNYA, MIST, BBIO, ALNY - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Tenaya Therapeutics IncOn Mar 27, Co Approves Restructuring PlanSEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March? - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

FY2025 Earnings Estimate for TNYA Issued By Chardan Capital - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March - Yahoo

Mar 25, 2025
pulisher
Mar 25, 2025

Top 3 Insider Stock Buys in March—Are They Still Good in April? - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Tenaya Therapeutics publishes preclinical data on TN-201 in cardiac function - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

15 Cheapest Stocks Insiders Are Buying In March - Insider Monkey

Mar 25, 2025
pulisher
Mar 24, 2025

Breakeven On The Horizon For Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - simplywall.st

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya reports promising gene therapy for heart condition By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics Says Gene Therapy Candidate Improves Heart Function in Preclinical Trial - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya reports promising gene therapy for heart condition - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) stock price dropped 13% last week; individual investors would not be happy - Yahoo

Mar 24, 2025
pulisher
Mar 24, 2025

Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Revolutionary Heart Disease Treatment: Gene Therapy Reverses Cardiac Damage in Landmark Study - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Tenaya Therapeutics announces $300M mixed shelf offering; shares down - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

Tenaya Therapeutics files for mixed shelf offering of up to $300 mln -March 21, 2025 at 04:16 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 20, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 20, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics to Present New Data on MYBPC3-Associated Hypertrophic Cardiomyopathy at ACC 2025 Annual Scientific Session - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics Announces Late Breaker and New Data - GlobeNewswire

Mar 19, 2025
pulisher
Mar 19, 2025

Major Breakthrough: Tenaya's Gene Therapy Trial Reveals Critical One-Year Heart Disease Data - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session - Yahoo Finance

Mar 19, 2025
pulisher
Mar 15, 2025

Canaccord Genuity Group Lowers Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $6.00 - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Analysts Issue Forecasts for TNYA Q1 Earnings - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Morgan Stanley Has Lowered Expectations for Tenaya Therapeutics (NASDAQ:TNYA) Stock Price - Defense World

Mar 14, 2025
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Kapitalisierung:     |  Volumen (24h):